Who are Trimo-San vaginal gel's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/trimo-san-vaginal-gel.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Trimo-San vaginal gel — Competitive Intelligence Brief

Trimo-San vaginal gel (Trimo-San vaginal gel) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vaginal pH regulator / Probiotic adjunct. Area: Gynecology / Infectious Disease.

marketed Vaginal pH regulator / Probiotic adjunct Gynecology / Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Trimo-San vaginal gel (Trimo-San vaginal gel) — The University of Texas Health Science Center, Houston. Trimo-San is a vaginal gel containing lactic acid and other ingredients that restore and maintain the normal acidic pH of the vaginal environment to prevent bacterial vaginosis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Trimo-San vaginal gel TARGET	Trimo-San vaginal gel	The University of Texas Health Science Center, Houston	marketed	Vaginal pH regulator / Probiotic adjunct

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vaginal pH regulator / Probiotic adjunct class)

The University of Texas Health Science Center, Houston · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Trimo-San vaginal gel — Competitive Intelligence Brief. https://druglandscape.com/ci/trimo-san-vaginal-gel. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab